DexCom, Inc. ( DXCM) - Key Metrics
DXCM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $3.26 | $0.69 | ? | ? |
| 2025Q3 | $3.09 | $0.73 | $1.69 | $1.48 |
| 2025Q2 | $2.95 | $0.46 | $0.77 | $0.53 |
| 2025Q1 | $2.65 | $0.27 | $0.47 | $0.25 |
DXCM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 24.00 |
| 2025Q3 | ? | 23.18 |
| 2025Q2 | ? | 47.59 |
| 2025Q1 | ? | 63.35 |
DXCM Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 1.86% | ? |
| 2025Q4 | 0.75% | ? |
| 2025Q3 | 2.20% | ? |
| 2025Q2 | 0.61% | ? |
| 2025Q1 | 0.36% | ? |
DXCM
Price: $74.77
52 week price:
Earnings Per Share: 2.33 USD
P/E Ratio: 25.91
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 3.0 million
Ebitda: 6.3 millionMarket Capitalization: 28.1 billion